| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. (HALO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. HALO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 777.8K | $53.66M | - | |
| Dir | 77.8K | $5.37M | - | |
| Dir | 43.7K | $3.01M | -1,625 | |
| Dir | 36.6K | $2.52M | - | |
| Dir | 23.7K | $1.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 12,000 | $42.58 | $510,918.60 | -4.6% | |
| Dec 7, 2020 | Kelley Kenneth J | Director | Sell | 35,086 | $41.00 | $1,438,526.00 | -14.9% | |
| Dec 2, 2020 | Kelley Kenneth J | Director | Sell | 31,792 | $41.00 | $1,303,472.00 | -11.9% | |
| Nov 27, 2020 | Kelley Kenneth J | Director | Sell | 19,671 | $41.37 | $813,850.37 | -3.5% | |
| Nov 25, 2020 | Daly James M | Director | Sell | 10,363 | $40.41 | $418,799.92 | -33.0% | |
| Nov 25, 2020 | Henderson Jeffrey William65 | Director | Sell | 24,498 | $40.08 | $981,757.35 | -34.0% | |
| Nov 25, 2020 | Torley Helen61 | President And CEO | Sale+OE | 50,000 | $40.73 | $2,036,567.72 | -4.8% | |
| Nov 20, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 12,000 | $38.76 | $465,176.09 | -4.1% | |
| Oct 20, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 12,000 | $30.43 | $365,148.00 | -7.6% | |
| Sep 21, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 12,000 | $26.91 | $322,884.00 | -7.0% |